DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)



company name or ticker

Investors' Radars Failed to Catch ZIOPHARM (ZIOP), Has Yours? - Tale of the Tape

Investors' Radars Failed to Catch ZIOPHARM (ZIOP), Has Yours? - Tale of the Tape

Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk

Why ZIOPHARM (ZIOP) is Poised to Beat Earnings Estimates? - Tale of the Tape

Surging Earnings Estimates Signal Good News for ZIOPHARM (ZIOP) - Tale of the Tape

Why ZIOPHARM Oncology, Inc. Zoomed Today

Is this meaningful or just another movement?

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind

Myraid Genetics, Sarepta Therapeutics, Questcor Pharmaceuticals, Ziopharm Oncology, and MannKind top the list of the most shorted biotechs.

4 Stocks Under $10 Making Big Moves

CytRx Directors Are $3M Richer With Well-Timed Stock Option Grants

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Mel

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Melanoma

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12
See More Articles...